Partial heart transplantation can ameliorate donor organ utilization.
congenital heart disease
valve repair/replacement
Journal
Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
revised:
23
09
2022
received:
08
08
2022
accepted:
05
10
2022
pubmed:
20
10
2022
medline:
6
1
2023
entrez:
19
10
2022
Statut:
ppublish
Résumé
The treatment of babies with unrepairable heart valve dysfunction remains an unsolved problem because there are no growing heart valve implants. However, orthotopic heart transplants are known to grow with recipients. Partial heart transplantation is a new approach to delivering growing heart valve implants, which involves transplantation of the part of the heart containing the valves only. In this review, we discuss the benefits of this procedure in children with unrepairable valve dysfunction. Partial heart transplantation can be performed using donor hearts with poor ventricular function and slow progression to donation after cardiac death. This should ameliorate donor heart utilization and avoid both primary orthotopic heart transplantation in children with unrepairable heart valve dysfunction and progression of these children to end-stage heart failure.
Sections du résumé
BACKGROUND
BACKGROUND
The treatment of babies with unrepairable heart valve dysfunction remains an unsolved problem because there are no growing heart valve implants. However, orthotopic heart transplants are known to grow with recipients.
AIM
OBJECTIVE
Partial heart transplantation is a new approach to delivering growing heart valve implants, which involves transplantation of the part of the heart containing the valves only. In this review, we discuss the benefits of this procedure in children with unrepairable valve dysfunction.
CONCLUSION
CONCLUSIONS
Partial heart transplantation can be performed using donor hearts with poor ventricular function and slow progression to donation after cardiac death. This should ameliorate donor heart utilization and avoid both primary orthotopic heart transplantation in children with unrepairable heart valve dysfunction and progression of these children to end-stage heart failure.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
5307-5312Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
van der Linde D, Konings EE, Slager MA, et al. Birth prevalence of congenital heart disease worldwide. J Am Coll Cardiol. 2011;58(21):2241-2247. doi:10.1016/j.jacc.2011.08.025
GBD Congenital Heart Disease Collaborators. Global, regional, and national burden of congenital heart disease, 1990-2017: A systematic analysis for the global burden of disease study 2017. Lancet Child Adolesc Health. 2020;4(3):185-200. doi:10.1016/s2352-4642(19)30402-x
Husain SA, Brown JW. When reconstruction fails or is not feasible: valve replacement options in the pediatric population. Semin Thorac Cardiovasc Surg: Pediatr Card Surg Ann. 2007;10(1):117-124. doi:10.1053/j.pcsu.2007.01.012
Alsoufi B. Aortic valve replacement in children: options and outcomes. J Saudi Heart Assoc. 2014;26(1):33-41. doi:10.1016/j.jsha.2013.11.003
Nicks R, Cartmill T, Bernstein L. Hypoplasia of the aortic root: the problem of aortic valve replacement. Thorax. 1970;25(3):339-346. doi:10.1136/thx.25.3.339
Manouguian S, Kirchhoff PG. Aortic and aortic-mitral annular enlargement. J Thorac Cardiovasc Surg. 1996;112(1):207. doi:10.1016/s0022-5223(96)70210-6
Schlein J, Simon P, Wollenek G, Base E, Laufer G, Zimpfer D. Aortic valve replacement in pediatric patients: 30 years single center experience. J Cardiothorac Surg. 2021;16(1):259. doi:10.1186/s13019-021-01636-2
He G-W. To be or not to be: mechanical versus biological prosthesis at the pulmonary valvular position. J Thorac Cardiovasc Surg. 2017;154(4):1379-1380. doi:10.1016/j.jtcvs.2017.06.012
Pragt H, van Melle JP, Javadikasgari H, et al. Mechanical valves in the pulmonary position: an international retrospective analysis. J Thorac Cardiovasc Surg. 2017;154(4):1371-1378. doi:10.1016/j.jtcvs.2017.04.072
Kostyunin AE, Yuzhalin AE, Rezvova MA, Ovcharenko EA, Glushkova TV, Kutikhin AG. Degeneration of bioprosthetic heart valves: update 2020. J Am Heart Assoc. 2020;9(19):018506. doi:10.1161/jaha.120.018506
Manji RA, Zhu LF, Nijjar NK, et al. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation. 2006;114(4):318-327. doi:10.1161/circulationaha.105.549311
Saleeb SF, Newburger JW, Geva T, et al. Accelerated degeneration of a bovine pericardial bioprosthetic aortic valve in children and young adults. Circulation. 2014;130(1):51-60. doi:10.1161/circulationaha.114.009835
McElhinney DB, Hennesen JT. The melody® valve and Ensemble® Delivery System for transcatheter pulmonary valve replacement. Ann NY Acad Sci. 2013;1291(1):77-85. doi:10.1111/nyas.12194
Feins EN, Chávez M, Callahan R, del Nido PJ, Emani SM, Baird CW. Experience and outcomes of surgically implanted melody valve in the pulmonary position. Ann Thorac Surg. 2021;111(3):966-972. doi:10.1016/j.athoracsur.2020.05.061
Hascoet S, Mauri L, Claude C, et al. Infective endocarditis risk after percutaneous pulmonary valve implantation with the melody and sapien valves. JACC: Cardiovasc Interv. 2017;10(5):510-517. doi:10.1016/j.jcin.2016.12.012
Cebotari S, Tudorache I, Ciubotaru A, et al. Use of fresh decellularized allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults. Circulation. 2011;124(11_suppl_1):115-123. doi:10.1161/circulationaha.110.012161
Neumann A, Sarikouch S, Breymann T, et al. Early systemic cellular immune response in children and young adults receiving decellularized fresh allografts for pulmonary valve replacement. Tissue Eng Part A. 2014;20(5-6):1003-1011. doi:10.1089/ten.tea.2013.0316
Rajab TK. Evidence-based surgical hypothesis: partial heart transplantation can deliver growing valve implants for congenital cardiac surgery. Surgery. 2021;169(4):983-985. doi:10.1016/j.surg.2020.07.051
Rajab TK, Zorrilla-Vaca A, Kavarana MN, Mokashi S, Sainathan S. Ross operation in neonates: a meta-analysis. Ann Thorac Surg. 2022;113(1):192-198. doi:10.1016/j.athoracsur.2020.11.008
Ross DN. Replacement of aortic and mitral valves with a pulmonary autograft. Lancet. 1967;290(7523):956-958. doi:10.1016/s0140-6736(67)90794-5
Etnel JRG, Grashuis P, Huygens SA, et al. The Ross procedure: A systematic review, meta-analysis, and microsimulation. Circ: Cardiovasc Qual Outcomes. 2018;11(12):004748. doi:10.1161/circoutcomes.118.004748
Takkenberg JJ, Klieverik LM, Schoof PH, et al. The Ross procedure. Circulation. 2009;119(2):222-228. doi:10.1161/circulationaha.107.726349
Milanesi O, Cerutti A, Biffanti R, Salvadori S, Gambino A, Stellin G. Heart transplantation in pediatric age. J Cardiovasc Med. 2007;8(1):67-71. doi:10.2459/01.jcm.0000247439.89946.20
Riggs KW, Kroslowitz BJ, Chin C, Zafar F, Morales DLS. Pondering higher-risk pediatric heart donors: can we use more. Ann Thorac Surg. 2020;110(1):198-205. doi:10.1016/j.athoracsur.2019.09.069
Smith CJ, McCulloch MD, Shirley DA, L'Ecuyer TJ. Pediatric heart transplant from an incompletely treated influenza a-positive donor. Pediatr Tranplant. 2019;23(8):13585. doi:10.1111/petr.13585
Barnes A, Gibson W. Pediatric heart transplant. Semin Pediatr Surg. 2021;30(2):151039. doi:10.1016/j.sempedsurg.2021.151039
Morrison AK, Gowda C, Tumin D, et al. Pediatric marginal donor hearts: trends in US national use, 2005-2014. Pediatr Tranplant. 2018;22(5):13216. doi:10.1111/petr.13216
Zafar F, Jaquiss RD, Almond CS, et al. Pediatric heart donor assessment tool (PH-DAT): A novel donor risk scoring system to predict 1-year mortality in pediatric heart transplantation. J Heart Lung Transplant. 2018;37(3):332-339. doi:10.1016/j.healun.2017.03.002
West LJ, Pollock-Barziv SM, Dipchand AI, et al. Abo-incompatible heart transplantation in infants. N Engl J Med. 2001;344(11):793-800. doi:10.1056/nejm200103153441102
Urschel S, McCoy M, Cantor RS, et al. A current era analysis of ABO incompatible listing practice and impact on outcomes in young children requiring heart transplantation. J Heart Lung Transplant. 2020;39(7):627-635. doi:10.1016/j.healun.2020.02.008
Kwon JH, Hill MA, Gerry B, et al. Cellular viability of partial heart transplant grafts in cold storage. Front Surg. 2021;8:8. doi:10.3389/fsurg.2021.676739
Hill MA, Kwon JH, Gerry B, et al. Immune privilege of heart valves. Front Immunol. 2021;12:12. doi:10.3389/fimmu.2021.731361
McVadon DH, Hardy WA, Boucek KA, et al. Effect of cardiac graft rejection on semilunar valve function: implications for heart valve transplantation. Cardiol Young. 2022:1-8. doi:10.1017/s104795112200258x